454 related articles for article (PubMed ID: 16497452)
1. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
Anal AK; Stevens WF; Remuñán-López C
Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
[TBL] [Abstract][Full Text] [Related]
2. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: swelling kinetics and drug delivery properties.
Lin WC; Yu DG; Yang MC
Colloids Surf B Biointerfaces; 2005 Aug; 44(2-3):143-51. PubMed ID: 16054345
[TBL] [Abstract][Full Text] [Related]
4. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
Wang LY; Gu YH; Su ZG; Ma GH
Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of ampicillin-conjugated gum arabic microspheres for sustained release.
Nishi KK; Antony M; Jayakrishnan A
J Pharm Pharmacol; 2007 Apr; 59(4):485-93. PubMed ID: 17430631
[TBL] [Abstract][Full Text] [Related]
6. Ionically cross-linked chitosan microspheres for controlled release of bioactive nerve growth factor.
Zeng W; Huang J; Hu X; Xiao W; Rong M; Yuan Z; Luo Z
Int J Pharm; 2011 Dec; 421(2):283-90. PubMed ID: 22001532
[TBL] [Abstract][Full Text] [Related]
7. Chitosan microparticle preparation for controlled drug release by response surface methodology.
Ko JA; Park HJ; Park YS; Hwang SJ; Park JB
J Microencapsul; 2003; 20(6):791-7. PubMed ID: 14594667
[TBL] [Abstract][Full Text] [Related]
8. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-alginate multilayer beads for controlled release of ampicillin.
Anal AK; Stevens WF
Int J Pharm; 2005 Feb; 290(1-2):45-54. PubMed ID: 15664129
[TBL] [Abstract][Full Text] [Related]
10. Formulation and in vitro characterization of spray dried microspheres of amoxicillin.
Raval JA; Patel JK; Patel MM
Acta Pharm; 2010 Dec; 60(4):455-65. PubMed ID: 21169137
[TBL] [Abstract][Full Text] [Related]
11. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline release from tripolyphosphate-chitosan cross-linked sponge: a preliminary in vitro study.
Shen EC; Wang C; Fu E; Chiang CY; Chen TT; Nieh S
J Periodontal Res; 2008 Dec; 43(6):642-8. PubMed ID: 18624950
[TBL] [Abstract][Full Text] [Related]
13. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
[TBL] [Abstract][Full Text] [Related]
14. Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.
Nayak UY; Gopal S; Mutalik S; Ranjith AK; Reddy MS; Gupta P; Udupa N
J Microencapsul; 2009 May; 26(3):214-22. PubMed ID: 18819029
[TBL] [Abstract][Full Text] [Related]
15. Optimisation and characterisation of bioadhesive controlled release tetracycline microspheres.
Govender S; Pillay V; Chetty DJ; Essack SY; Dangor CM; Govender T
Int J Pharm; 2005 Dec; 306(1-2):24-40. PubMed ID: 16246512
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process.
Wang LY; Gu YH; Zhou QZ; Ma GH; Wan YH; Su ZG
Colloids Surf B Biointerfaces; 2006 Jul; 50(2):126-35. PubMed ID: 16787743
[TBL] [Abstract][Full Text] [Related]
17. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
Lin CC; Fu CH
Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
[TBL] [Abstract][Full Text] [Related]
18. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.
Gupta KC; Jabrail FH
Carbohydr Res; 2006 May; 341(6):744-56. PubMed ID: 16499893
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate.
Liu YF; Huang KL; Peng DM; Ding P; Li GY
Int J Biol Macromol; 2007 Jun; 41(1):87-93. PubMed ID: 17292465
[TBL] [Abstract][Full Text] [Related]
20. Moulded cross-linked chitosan matrix systems for controlled drug release.
Tarirai C; Enslin GM; Steenekamp JH; Hamman JH
Pharm Dev Technol; 2011 Aug; 16(4):295-301. PubMed ID: 20214415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
